Published in Adv Drug Deliv Rev on April 29, 2004
Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem (2006) 1.71
Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc Natl Acad Sci U S A (2006) 1.65
A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. ACS Nano (2010) 1.29
Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange. Nano Lett (2011) 1.23
Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev (2012) 1.09
Characterization of ZnO nanoparticles grown in presence of folic acid template. J Nanobiotechnology (2012) 0.88
Targeting folate receptor alpha for cancer treatment. Oncotarget (2016) 0.84
Prospects in folate receptor-targeted radionuclide therapy. Front Oncol (2013) 0.83
Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy. Nanotechnol Sci Appl (2010) 0.78
Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy. Eur J Nucl Med Mol Imaging (2009) 0.78
Folate-immunoglobulin G as an anticancer therapeutic antibody. Bioconjug Chem (2010) 0.78
Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors. Mol Pharm (2016) 0.75
Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging. ACS Nano (2012) 1.16
Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nucl Med (2003) 1.14
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol (2003) 1.03
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Basic Res Cardiol (2013) 0.99
Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine (2010) 0.98
Interstitial oxide ion conductivity in the layered tetrahedral network melilite structure. Nat Mater (2008) 0.95
Fate of silica nanoparticles in simulated primary wastewater treatment. Environ Sci Technol (2009) 0.92
Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion. Nucl Med Biol (2007) 0.92
An automated SPE-based high-yield synthesis of [11C]acetate and [11C]palmitate: no liquid-liquid extraction, solvent evaporation or distillation required. Nucl Med Biol (2011) 0.91
Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging. Dalton Trans (2011) 0.89
Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects. Nucl Med Biol (2009) 0.86
A convenient route to [68Ga]Ga-MAA for use as a particulate PET perfusion tracer. Appl Radiat Isot (2008) 0.85
The folate receptor as a molecular target for tumor-selective radionuclide delivery. Nucl Med Biol (2003) 0.83
Open metal sites within isostructural metal-organic frameworks for differential recognition of acetylene and extraordinarily high acetylene storage capacity at room temperature. Angew Chem Int Ed Engl (2010) 0.83
Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. Nucl Med Biol (2002) 0.83
Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Nucl Med Biol (2008) 0.83
Synthesis of porous hollow silica nanostructures using hydroxyapatite nanoparticle templates. Chem Commun (Camb) (2010) 0.83
Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. J Am Chem Soc (2005) 0.82
Coupled commensurate cation and charge modulation in the tunneled structure, Na(0.40(2))MnO(2). J Am Chem Soc (2011) 0.81
Magnetoelastic coupling and symmetry breaking in the frustrated antiferromagnet alpha-NaMnO2. Phys Rev Lett (2007) 0.81
Phase separation and suppression of the structural and magnetic transitions in superconducting doped iron tellurides, Fe(1+x)Te(1-y)S(y). J Am Chem Soc (2010) 0.80
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals. J Pharm Sci (2009) 0.80
Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs. Nucl Med Biol (2012) 0.79
Equivalence of arterial and venous blood for [11C]CO2-metabolite analysis following intravenous administration of 1-[11C]acetate and 1-[11C]palmitate. Nucl Med Biol (2013) 0.79
Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga. Nucl Med Biol (2009) 0.78
Gold(III) bis-thiosemicarbazonato complexes: synthesis, characterization, radiochemistry and X-ray crystal structure analysis. Nucl Med Biol (2009) 0.76
Cerebral metabolism in dogs assessed by (18)F-FDG PET: a pilot study to understand physiological changes in behavioral disorders in dogs. J Vet Med Sci (2009) 0.76
Surface chemistry of photoluminescent F8BT conjugated polymer nanoparticles determines protein corona formation and internalization by phagocytic cells. Biomacromolecules (2015) 0.75
When small is better. Nat Mater (2009) 0.75
Crystal engineering in two dimensions: Surface attraction. Nat Mater (2010) 0.75
The use of combinatorial chemical vapor deposition in the synthesis of Ti(3-delta)O4N with 0.06 < delta < 0.25: a titanium oxynitride phase isostructural to anosovite. J Am Chem Soc (2007) 0.75
Crossover from positive to negative magnetoresistance in a spinel. J Am Chem Soc (2004) 0.75
A new series of sodium cobalt oxyhydrates. Chem Commun (Camb) (2004) 0.75
Synthesis, structure, and magnetic properties of a novel pillared layered iron(III) arsenate, [4,4'-bpyH2]3[Fe9(H2O)6F3(HAsO4)12(AsO4)2].2H2O. J Phys Chem B (2007) 0.75
Synthesis and characterization of a porous magnetic diamond framework, Co3(HCOO)6, and its N2 sorption characteristic. Inorg Chem (2005) 0.75
Visualizing the historical and contemporary differences in mortality between the United States and Canada using Lexis diagrams. Can J Public Health (2012) 0.75
Incommensurate magnetism in FeAs strips: neutron scattering from CaFe(4)As(3). Phys Rev Lett (2011) 0.75
Iodine as an oxidant in the topotactic deintercalation of interstitial iron in Fe(1+x)Te. J Am Chem Soc (2010) 0.75
Phase separation and superconductivity in Fe(1+x)Te(0.5)Se(0.5). Chem Commun (Camb) (2011) 0.75